WebJun 2, 2024 · This is a 2-part interview. To view part 1, click here. Neurolutions, a medical device company, announced in April that the FDA had granted de novo market authorization and breakthrough device designation for its IpsiHand Upper Extremity Rehabilitation System, making it the first FDA-approved, device-leveraging brain-computer interface technology … WebApr 26, 2024 · The FDA assessed the safety and effectiveness of the IpsiHand System device through clinical data submitted by the company, including an unblinded study of 40 patients over a 12-week trial. All participants demonstrated motor function improvement with the device over the trial.
Evaluation of Automatic Class III Designation (De Novo) …
WebAug 11, 2024 · Eric Leuthardt, MD, and Dan Moran created the IpsiHand, the first brain–computer interface to be approved by the FDA for stroke, and the first FDA-approved thought-controlled device. Collaboration across disciplines is integral at WashU, often yielding life-changing discoveries. WebBefore you get started, make sure you qualify for IpsiHand screening and therapy. Based on FDA indications and Neurolutions requirements, candidates are required to meet the following criteria: Adult age 18 or older. 6 months or more post-stroke. Experience post-stroke upper extremity weakness. Resident of the United States china self-motion shoe cover machine
FDA Authorizes Marketing of Noninvasive Brain-Computer …
WebThe Neurolutions IpsiHand Upper Extremity Rehabilitation System (a.k.a. Neurolutions System or IpsiHand System) detects goal-oriented brain activity using non-invasive EEG … WebApr 23, 2024 · The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper... WebApr 27, 2024 · IpsiHand is intended for stroke survivors who have chronic difficulty in moving or controlling an arm and hand. Most patients recover some movement in the first … chinas electricity production 2020